Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands

Brain Research

Volumn 809, Issue 2, 1998, Pages 302-306

  Giraudo, Silvia Q ^a,b   Billington, Charles J ^a,b,c   Levine, Allen S ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Minnesota   (United States)

Author keywords

Food intake; MC4 receptor; MT II; Paraventricular nucleus; SHU9119

Indexed keywords

MELANOCORTIN RECEPTOR;

ALLELE; ARTICLE; BODY WEIGHT; DRUG EFFECT; DRUG POTENCY; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION REGULATION; HYPOTHALAMUS; LIGAND BINDING; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR BINDING; THALAMUS MIDLINE NUCLEUS;

ALPHA-MSH; ANIMALS; EATING; LIGANDS; MALE; MELANOCYTE-STIMULATING HORMONES; NEUROPEPTIDES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN;

EID: 0032476779     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00837-3     Document Type: Article

References (14)

1. Bray G.A., York D.A. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59:1979;719-809.
2. R.D. Cone, D. Lu, S. Koppula, D.I. Vage, H. Klungland, B. Boston, W. Chen, D.N. Orth, C. Pouton, R.A. Kesterson, The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation, Recent Prog. Horm. Res., 51 (1996) 287-317; discussion, 318 (1996).
3. R.D. Cone, D. Lu, S. Koppula, D.I. Vage, H. Klungland, B. Boston, W. Chen, D.N. Orth, C. Pouton, R.A. Kesterson, The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation, Recent Prog. Horm. Res., 51 (1996) 287-317; discussion, 318 (1996).
4. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168. see comments.
5. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
6. Lu D., Willard D., Patel I.R., Kadwell S., Overton L., Kost T., Luther M., Chen W., Woychik R.P., Wilkison W.O.et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 371:1994;799-802.
7. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994;1298-1308.
8. Mountjoy K.G., Wong J. Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol. Cell. Endocrinol. 128:1997;171-177.
9. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, San Diego, 1986.
10. Poggioli R., Vergoni A.V., Bertolini A. ACTH-(1-24) and α-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides. 7:1986;843-848.
11. Seeley R.J., Yagaloff K.A., Fisher S.L., Burn P., Thiele T.E., van Dijk G., Baskin D.G., Schwartz M.W. Melanocortin Receptors in Leptin Effects. 390:1997;349.
12. Thiele T.E., van Dijk G., Yagaloff K.A., Fisher S.L., Schwartz M., Burn P., Seeley R.J. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am. J. Physiol. 274:1998;R248-54.
13. Wolff G.L., Galbraith D.B., Domon O.E., Row J.M. Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutations. J. Hered. 69:1978;295-298.
14. Wolff G.L., Roberts D.W., Galbraith D.B. Prenatal determination of obesity, tumor susceptibility, and coat color pattern in viable yellow (Avy/a) mice. The yellow mouse syndrome. J. Hered. 77:1986;151-158.